fingolimod hydrochloride has been researched along with Ischemic Stroke in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, P; Jiang, F; Li, M; Li, N; Liang, Z; Liu, B; Wang, M; Wang, P; Yao, Y; Yuan, J; Zhao, C; Zhen, J; Zhu, R | 1 |
| Choi, JW; Gaire, BP | 1 |
| Chen, CP; Chew, WS; Chua, XY; Herr, DR; Ho, LTY; Lai, MKP; Lam, BWS; Ong, WY; Xiang, P | 1 |
| Bayat, M; Haghani, M; Naseh, M; Rafati, A; Vatanparast, J | 1 |
| Chen, H; Chen, Q; Chu, Y; Guo, Q; Jiang, C; Li, C; Li, X; Liu, P; Luo, Y; Ning, T; Song, H; Su, B; Sun, T; Wang, Y; You, H; Zhang, T; Zhang, Y; Zhao, Z; Zhou, W; Zhou, Z | 1 |
4 review(s) available for fingolimod hydrochloride and Ischemic Stroke
| Article | Year |
|---|---|
The efficacy and safety of fingolimod plus standardized treatment versus standardized treatment alone for acute ischemic stroke: A systematic review and meta-analysis.
Topics: Fingolimod Hydrochloride; Humans; Immunotherapy; Ischemic Stroke; Stroke | 2022 |
Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.
Topics: Animals; Brain Damage, Chronic; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Humans; Infarction, Middle Cerebral Artery; Inflammation; Ischemic Stroke; Lysophospholipids; Neovascularization, Physiologic; Nerve Tissue Proteins; Neuroprotective Agents; Phosphotransferases (Alcohol Group Acceptor); Rats; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2021 |
Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment.
Topics: Aldehyde-Lyases; Alzheimer Disease; Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Dementia, Vascular; Drug Delivery Systems; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Humans; Infarction, Middle Cerebral Artery; Inflammation; Ischemic Stroke; Lysophospholipids; Mice; Mice, Knockout; Neurodegenerative Diseases; Phosphotransferases (Alcohol Group Acceptor); Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2021 |
The emerging role of FTY720 as a sphingosine 1-phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms.
Topics: Animals; Brain Ischemia; Endothelial Cells; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Ischemic Stroke; Lysophospholipids; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Stroke | 2021 |
1 other study(ies) available for fingolimod hydrochloride and Ischemic Stroke
| Article | Year |
|---|---|
Macrophage-Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke.
Topics: Animals; Cell Line, Tumor; Cellular Microenvironment; Fingolimod Hydrochloride; Humans; Hydrogen Peroxide; Inflammation; Ischemic Stroke; Lysosomes; Macrophages; Manganese Compounds; Nanoparticles; Nanospheres; Neurons; Neuroprotection; Oxidative Stress; Oxides; Oxygen; Primary Cell Culture; Rats; Reperfusion Injury | 2021 |